Coronavirus treatment remdesivir will reach patients this week, says developer Gilead
A possible COVID19 treatment, remdesivir could reach hospitalized patients this week, says the CEO of developer Gilead. “The data shows that remdesivir has a clear-cut significant positive effect in diminishing the time to recovery,” said Dr. Anthony Fauci, the government's top infectious-disease expert, during a White House press conference last week.
recovery remdesivir fauci
FoxnewsRelated Articles
US STOCKS-Nasdaq closes at all-time high as strong tech sector offsets jobless data
Gains in Apple Inc - the only publicly listed U.S. company to cross the $2 trillion market value milestone - Amazon.com Inc and Microsoft Corp underpinned the three main indexes' gains as investors bet they would ride out the economic crisis. Separate data from the Philadelphia Fed showed a business conditions index fell more than expected in August. "
high recovery sp
Yahoo
Data on Gilead's remdesivir show no benefit for coronavirus patients
The antiviral medicine remdesivir from Gilead Sciences failed to speed the improvement of patients with Covid-19 or prevent them from dying, according to results from a long-awaited clinical trial conducted in China. Results are expected soon from a Gilead-run study in severe Covid-19 patients, although that study may be difficult to interpret because the drug is not compared to patients receiving only standard treatment.
data study remdesivir
Google